Imagine Eyes Partners with Emsere to Expand Access to Advanced Retinal Imaging in Clinical Trials
Imagine Eyes, a pioneer company in high-resolution ophthalmic imaging, is pleased to announce a distribution agreement with Emsere, a global leader in clinical trial equipment supply and solutions. Through this collaboration, Imagine Eyes’ flagship product, the rtx1™ Adaptive Optics Retinal Camera, will become more accessible to clinical trial sites worldwide.
The rtx1 is known for its unparalleled ability to image the retina at the cellular level. This enables highly sensitive assessments of retinal diseases, ultimately unraveling the effects of innovative treatments. By integrating this breakthrough technology into clinical trials, Imagine Eyes and Emsere remain committed to accelerating the development of ophthalmic therapies.
“At Imagine Eyes, we are dedicated to transforming the field of retinal imaging with innovative solutions that redefine what’s possible” said Nicolas Chateau, CEO at Imagine Eyes. “Emsere’s global reach and expertise in clinical trial equipment supply make them the ideal partner to help us bring the most advanced imaging technologies to clinical trials worldwide.”
Emsere was selected for their strong track record in supplying clinical trial sites with high-quality equipment, its global operational excellence, and its commitment to supporting research teams at every stage of the clinical trial process.
“We are excited to collaborate with Imagine Eyes to equip clinical trial sites with state-of-the-art imaging technology” said Jon Raven, CCO of Emsere. “By bringing the rtx1 Adaptive Optics Retinal Camera to the global research community, we can further support the groundbreaking research in ophthalmic trials, striving to improve patient outcomes.”
For more information about Imagine Eyes’ advanced retinal imaging technology, discover the rtx1 AO retinal camera and the published litterature.
To learn more about Emsere’s clinical trial solutions, visit www.emsere.com.
About Imagine Eyes: Imagine Eyes is a leading innovator in high-resolution retinal imaging. By enabling doctors to examine the retina at the cellular scale, the company is committed to advancing eye science and supporting the development of effective treatments for sight-threatening diseases.
About Emsere: Emsere is a global leader in clinical trial solutions, offering a wide range of products and services designed to support research teams at every stage of the trial process. The company is dedicated to advancing clinical research through innovation, quality, and unparalleled service.